oa Digitalis Toxicity and Fab Fragment

References

1. Eichhorn EJ, Gheorghiade M. Digoxin-New perspective on an old Drug. NEJM. 2002; 347::1394–1395.
   [Google Scholar]
2. Aronson JK. An account of the foxglove and its medical use, 1785–1985, including a Facsimile of the original monograph. London, England: Oxford University Press 1985.
   [Google Scholar]
3. Estes JW, White PD. William Withering and the purple foxglove. Scientific American. 1965; 212::110–119.
   [Google Scholar]
4. Groves MJ, Bis set NG. A note on the use of topical digitalis prior to William Withering. J Ethnopharm. 1991; 35::99–103.
   [Google Scholar]
5. National Prescription Audit, p.27. Ambler, Pa:Gosselin. 9th edition.
6. Yasui-Furukori N, Kaneko S. Digitalis intoxication induced by paroxetine co-administration. Lancet. 2006; 367::788.
   [Google Scholar]
7. Mason DT, Am J, Cardiol. 1971; 27::546–559.
   [Google Scholar]
8. http://www.emedicine.com/med/topic568.htm .
9. Dasgupta A, Datta P. Rapid Detection of Oleander Poisoning Using Digoxin Immunoassays: Comparison of Five Assays. The Drug Monit. 2004; 26::658.
   [Google Scholar]
10. Eddieston M, Ariaratnam CA, Sjostrom L. Acute yellow oleander (Thevetia peruviana) poisoning: Cardiac arrhythmias, electrolyte disturbances, and serum cardiac glycoside concentrations on presentation to hospital. Heart. 2000; 83::301.
    [Google Scholar]
11. Eddleston M, Rajapakse S, Rajakanthan . Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander: A randomised controlled trial. Lancet. 2000; 355::967.
    [Google Scholar]
12. Scheinost ME. Digoxin toxicity in a 26-year-old woman taking a herbal dietary supplement. J Am Osteopath Assoc. 2001; 101::444.
    [Google Scholar]
13. Barrueto F Jr, Jortani SA, Valdes R Jr. Cardioactive steroid poisoning from an herbal cleansing preparation. Ann Emerg Med. 2003; 41::396.
    [Google Scholar]
14. Hanratty CG, McGlinchey P, Johnston Gt, Passmore AP. Differential pharmacokinetics of digoxin in elderly patients. Drugs Aging. 2000; 17::353.
    [Google Scholar]
15. Miura T, Kojima R, Sugiura Y. Effect of aging on the incidence of digoxin toxicity. Ann Pharmacother. 2000; 34::427.
    [Google Scholar]
16. Lely AH, van Enter CHJ. Large-scale digitoxin intoxication. Br Med J. 1970; 3::737–740.
    [Google Scholar]
17. Sprague HB, White PD, Kellogg JF. Disturbances of vision due to digitalis: Review of the literature and report of cases. JAMA. 1925; 85::716–720.
    [Google Scholar]
18. Carroll FD. Visual symptoms caused by digitalis. Am J Ophthalmol. 1945; 28::373–376.
    [Google Scholar]
19. Hoffman BF, Bigger JT Jr. Digitalis and allied cardiac glycosides. In: Gilman AGRail TWNies ASTaylor P, eds. Goodman and Gilman \s The Pharmacological Basis of Therapeutics. 8th ed. New York: Pergamon Pr 1990;:814–839.
    [Google Scholar]
20. Kelly RA, Smith TW. Recognition and management of digitalis toxicity. Am J Cardiol. 1992; 69:18:108G–118G.
    [Google Scholar]
21. Hess T, Stucki P, Barandun S. Antibody treatment of digoxin intoxication in a patient with renal failure. Dtsch Med Wochenschr. 1979; 104::1273.
    [Google Scholar]
22. Nuwayhid NF, Johnson GF. Digoxin elimination in a functionally anephric patient after digoxin-specific Fab fragment therapy. Ther Drug Monit. 1989; 11::680.
    [Google Scholar]
23. Rabetoy GM, Price CA, Findlay JW. Treatment of digoxin intoxication in a renal failure patient with digoxin-specific antibody fragments and plasmapheresis. Am J Nephrol. 1990; 10::518.
    [Google Scholar]